52Nd Annual Meeting January 23–27, 2016
Total Page:16
File Type:pdf, Size:1020Kb
FAST, EFFECTIVE & PROVEN STS 52 The Society of Thoracic Surgeons ND ANNUAL MEETING Only flowable hemostat proven in cardiovascular surgery to reduce1-5: · blood transfusions · minor complications* Also proven to reduce: · revisions for bleeding · hemostasis time * Defined as either renal failure, respiratory insufficiency, or inotropic support lasting more than 24 hours. VISIT BOOTH #210 FOR ALL THE RESULTS OR VISIT WWW.FLOSEAL.COM FLOSEAL Hemostatic Matrix Indication FLOSEAL Matrix is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical. Selected Important Risk Information for FLOSEAL Matrix Do not inject or compress FLOSEAL Matrix into blood vessels. Do not apply FLOSEAL Matrix in the absence of active blood flow, e.g., while the vessel is clamped or bypassed, as extensive intravascular clotting and ND even death may result. 52 ANNUAL Do not use FLOSEAL Matrix in patients with known allergies to materials of bovine origin. Do not use FLOSEAL Matrix in the closure of skin incisions because it may interfere with the healing of the skin edges. FLOSEAL Matrix contains Thrombin made from human plasma. It may carry a risk of transmitting infectious agents, e.g., viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. 23–27, 2016 JANUARY MEETING FLOSEAL Matrix is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis. Excess FLOSEAL Matrix (material not incorporated in the hemostatic clot) should always be removed by gentle irrigation from the site of application. FLOSEAL Matrix swells by approximately 10% to 20% after product is applied. Maximum swell volume is PHOENIX, ARIZONA achieved within about 10 minutes. The safety and effectiveness of FLOSEAL Matrix has not been established in children under 2 years of age and pregnant women. Do not use air to remove residual FLOSEAL Matrix from Applicator tip. The Applicator tips should not be cut. Do not use FLOSEAL Matrix on bone surfaces where adhesives, such as methylmethacrylate or other acrylic adhesives, will be required to attach a prosthetic device. JANUARY 23–27, 2016 Rx Only. For safe and proper use of this device, refer to the full Instructions for Use. References: 1. Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg. 2009;88:1520-1526. 2. SURGIFLO Hemostatic Matrix Kit Instructions for Use. Somerville, NJ: J&J Wound Management. 2014. 3. VITAGEL Surgical Hemostat Instructions for Use. Malvern, PA. Orthovita, Inc. 2012. 4. D-STAT Clamp Accessory Topical Hemostat Instructions for Use. Minneapolis, MN. Vascular Solutions, Inc. 2013. 5. FLOSEAL Hemostatic Matrix Instructions for Use. Hayward, CA: Baxter Healthcare Corporation. Baxter and Floseal are registered trademarks of Baxter International Inc. USMP/9/15-0033 11/2015 ABSTRACT BOOK NOTE: Prints CMYK. All linked images are production ready. BBS5-025_USMP9150033_Floseal_STS_Abstract_Ad.inddTrim Size: 1 5.125" x 8.25" 12/7/15 1:13 PM STS 52 The Society of Thoracic Surgeons Commitment to The Society of Thoracic Surgeons gratefully acknowledges the following companies ND for providing educational grants for the STS 52nd Annual Meeting. CardioThoracic Surgery ANNUAL MEETING Comprehensive and Innovative Solutions This list is accurate as of December 15, 2015. STS Platinum Benefactor Provided $50,000 or above Abbott Vascular Adjunct Hemostat Solutions STS Gold Benefactor Provided $25,000-$49,999 Medtronic Endoscopic and STS Silver Benefactors Clip Appliers Thoracotomy Staplers Provided $10,000-$24,999 Ethicon HeartWare St Jude Medical Please visit us at STS Advanced Energy Booth #401 Trocars Wound Closure Solutions JANUARY 23–27, 2016 JANUARY MatrixRIB® Sternal ZIPFIX® Titanium Sternal Fixation System System Fixation System © 2015 Ethicon US, LLC. 043666-151119 DSUS/CMF/1115/0474 PROGRAMGENERAL INFORMATIONPARTICIPANTS MISSION STATEMENT e mission of e Society of oracic Surgeons is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy. OVERALL MEETING OBJECTIVE e overall objective of this meeting is to provide a forum for all cardiothoracic surgeons and their teams to learn the most up-to-date information on research, surgical techniques, patient management, and social, ethical, and political issues in order to maintain the highest level of care for the cardiothoracic patient. STS CONTINUING MEDICAL EDUCATION (CME) MISSION STATEMENT e continuing medical education mission of e Society of oracic Surgeons is to provide a forum for reporting results of scientic research and for updating information in the disciplines of cardiovascular, general thoracic and congenital heart surgery. e principal continuing education programs conducted by the Society include an annual scientic meeting, self-study programs, and other stand-alone meetings. e Annual Meeting is composed of peer-reviewed scientic abstracts, invited overview presentations, small group presentations, presentations on new technologies and video programs. e broad scope of topics related to cardiothoracic surgery is covered during each Annual Meeting. In addition to and separate from the national meeting, topical meetings are held that focus on relevant information needs of cardiothoracic surgeons. ese educational sessions frequently highlight a multidisciplinary approach and include content relevant to cardiothoracic surgeons as well as other physicians and health care providers in related disciplines. STS programs are developed and provided with the intent of conrming existing knowledge base, imparting new knowledge, and promoting competence in the content areas covered for cardiothoracic surgeons, residents, and their allied health care providers. Amended by the STS Board of Directors: January 25, 2009 FUTURE MEETINGS OF THE SOCIETY OF THORACIC SURGEONS STS/ELSO ECMO Symposium March 11–13, 2016 Tampa, Florida Advances in Quality & Outcomes September 28–30, 2016 Baltimore, Maryland Coding Workshop November 3–5, 2016 New Orleans, Louisiana STS 53rd Annual Meeting January 21–25, 2017 Houston, Texas e information in this Abstract Book is accurate as of December 9, 2015. STS 52nd Annual Meeting Abstract Book. © e Society of oracic Surgeons 2016. All rights reserved. 52nd Annual Meeting Abstract Book 1 TABLE OF CONTENTS STS Mission Statement .........................................................1 Overall Meeting Objective ...................................................... 1 CME Mission Statement ....................................................... 1 Program at a Glance ........................................................... 4 CME Information............................................................. 6 Rules Regarding Oral Presentations and Scientic Posters ............................ 10 Commercial Relationships of Program Planning Members, STS Sta, and Abstract Reviewers .....................................................12 STS/AATS Tech-Con 2016.....................................................30 STS/SCA: Integrating Perioperative Echocardiography Into Cardiac Surgical Clinical Decision Making .................................................. 42 STS/CHEST: Primer on Advanced and erapeutic Bronchoscopy .................... 44 Cardiopulmonary Bypass Simulation Course ...................................... 46 Acquired and Congenital Heart Surgery Symposium ................................ 50 Practice Management Summit .................................................. 52 STS/AATS Critical Care Symposium ............................................ 54 Residents Symposium: Transitioning From Residency to a Successful Practice ............ 56 ACC @ STS .................................................................58 How To: Technical Tricks and Pitfalls to Simplify Cardiac Surgery Procedures ........... 62 Parallel Surgical Symposium: Congenital ......................................... 66 Parallel Surgical Symposium: General oracic .................................... 68 Resuscitation of Patients Who Arrest After Cardiac Surgery .......................... 70 CT Surgery Interprofessional Education Symposium ............................... 72 J. Maxwell Chamberlain Memorial Papers ........................................ 76 Richard E. Clark Memorial Papers .............................................. 82 Presidential Address: Mark S. Allen .............................................. 87 Adult Cardiac Session: Arrhythmia .............................................. 88 Basic Science Research: Adult Cardiac ........................................... 94 Basic Science Research: General oracic ........................................ 104 Congenital Session: Adult Congenital ........................................... 110 Critical Care ............................................................... 116 General oracic Session: New Technology ...................................... 124 Quality Improvement Initiatives in oracic Surgery ............................... 132 STS/CATS/CSCS: Adding New Dimensions to Your Surgical Practice ............... 138 Redening Practice rough Quality and Evidence: What’s New? .................... 140 Adult Cardiac Session: Aorta I ................................................. 148 Adult Cardiac Session: Ischemic ..............................................